ストックスクリーナーアプリを入手
2.99
0.99%
-0.03
アフターアワーズ：
3.09
0.10
+3.34%
前日終値:
$3.02
開ける：
$3
24時間の取引高:
34,740
Relative Volume:
0.07
時価総額：
$1.63M
収益：
-
当期純損益:
$-4.14M
株価収益率:
-0.4124
EPS:
-7.2511
ネットキャッシュフロー:
$-4.79M
1週間 パフォーマンス:
+0.34%
1か月 パフォーマンス:
-34.72%
6か月 パフォーマンス:
-49.18%
1年 パフォーマンス:
-74.96%
1日の値動き範囲:
$2.95
$3.04
1週間の範囲:
$2.91
$3.155
52週間の値動き範囲:
$2.84
$22.20
Bone Biologics Corp Stock (BBLG) Company Profile
名前
Bone Biologics Corp
セクター
電話
(781) 552-4452
住所
2 BURLINGTON WOODS DRIVE,, BURLINGTON
BBLG を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BBLG
Bone Biologics Corp
|
2.99 | 4.85M | 0 | -4.14M | -4.79M | -7.2511 |
|
ABT
Abbott Laboratories
|
126.35 | 220.16B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
105.84 | 157.03B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
400.69 | 154.21B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
91.97 | 119.08B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.49 | 46.93B | 5.69B | 4.15B | 623.10M | 6.95 |
Bone Biologics Corp (BBLG) 最新ニュース
When is Bone Biologics Corporation Equity Warrant stock expected to show significant growthInvest confidently with data-driven strategies - jammulinksnews.com
Trend analysis for Bone Biologics Corporation this weekSmart Trade Mapping with Entry Details - Newser
Pattern recognition hints at Bone Biologics Corporation upsideFree Pattern Detection for Entry Confirmation - Newser
How volatile is Bone Biologics Corporation Equity Warrant stock compared to the marketStock Market Forecasts For 2025 - jammulinksnews.com
What are Bone Biologics Corporation Equity Warrant company’s key revenue driversHigh-return market picks - jammulinksnews.com
Sectors Driving Future Growth for Bone Biologics Corporation StockCapital Growth Picks - Newser
How Interest Rate Changes Impact Bone Biologics Corporation Equity Warrant Stock PerformanceWealth Building Stock Portfolio - Newser
Bone Biologics Corporation Stock Support and Resistance Levels You Should KnowInvestor Friendly Risk Reward - Newser
Bone Biologics (OTC:BBLG) Stock Price Down 0.3% – What’s Next? - Defense World
Should You Buy MPG(max property group)Protected Capital Trading Plan - Newser
Is Bone Biologics Corporation a good long term investmentHigh-yield capital appreciation - Autocar Professional
Orthobiologics Market Growth in Future Scope 2025-2032 | Zimmer Biomet, Bone Biologics Corp., Globus Medical - openPR.com
What analysts say about Bone Biologics Corporation Equity Warrant stockFree Predictions - Autocar Professional
Bone Biologics Corporation Equity Warrant Stock Analysis and ForecastPowerful growth strategies - jammulinksnews.com
(BBLGW) Technical Pivots with Risk Controls - news.stocktradersdaily.com
What analysts say about Bone Biologics Corporation stockOverwhelming financial success - PrintWeekIndia
Bone Biologics Corporation Stock Analysis and ForecastTriple-digit wealth increases - jammulinksnews.com
What drives Aardvark Therapeutics Inc. stock priceLightning-fast capital gains - jammulinksnews.com
What drives Bone Biologics Corporation stock priceUnprecedented profit potential - jammulinksnews.com
How Austin Gold Corp. stock reacts to Fed policy changesProtected Capital Trading Plan - beatles.ru
Best Stocks for Value Investors Premium Financial Forecasting ToolsExplosive earning power - jammulinksnews.com
What analysts say about Deluxe Corporation stockBreakthrough stock performance - jammulinksnews.com
What drives Bone Biologics Corporation Equity Warrant stock priceTremendous growth opportunities - jammulinksnews.com
Why NTRA stock is on top investor watchlistsRapid Gain Targets - Newser
Why i3 Verticals Inc. stock attracts strong analyst attentionFree Access to Group - Newser
How Bone Biologics Corporation stock performs during market volatilityROI Driven Alerts - Newser
What makes Bone Biologics Corporation Equity Warrant stock price move sharplyLow Risk ROI Maximization - Newser
What makes Bone Biologics Corporation stock price move sharplyMulti Bagger Alerts - Newser
When ABPWW stock expected to show significant growthIs STEL stock a good long term investment optionFree Best Stocks to Buy Today - Newser
What makes Legato Merger Corp. III stock price move sharplyFree Trading Group - Newser
What makes AGMH stock price move sharplyFree Growth Investment Group - Newser
Why Bone Biologics Corporation stock attracts strong analyst attentionCapital Efficient Investment Tips - Newser
When HOVRW stock expected to show significant growthIs WYNN stock a good long term investment optionTop Analyst Picks - Newser
Why Nu Skin Enterprises Inc. stock attracts strong analyst attentionTechnical Breakout List - Newser
Biocon Biologics gets UK MHRA nod for biosimilars Vevzuo, Evfraxy - Business Standard
Bone Biologics (OTC:BBLG) Shares Down 3.6% – Should You Sell? - Defense World
NBSTU SEC FilingsNewbury Street Acquisition Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Biocon Biologics gets EU nod for two drugs to treat bone diseases - Business Standard
(BBLGW) Long Term Investment Analysis - news.stocktradersdaily.com
Demineralized Bone Matrix Market Report For M&A, Expansion, And Competitive Benchmarking (2025–2034) - EIN News
Why Venus Concept Shares Are Trading Higher By Over 32%; Here Are 20 Stocks Moving Premarket - inkl
Bone Biologics Secures $5M Public Offering with Potential for Additional $10M from Warrants - Stock Titan
Penny Stocks Worth WatchingJune 29th - MarketBeat
Bone Biologics (BBLG) Announces $5 Million Public Offering - GuruFocus
BBLG: Making Major Step Toward Commercialization - Research Tree
Bone Biologics ($BBLG) Skyrockets 80.5% in Premarket on Patent Filing Bombshell: What’s Fueling the Frenzy? - RagingBull
Bone Biologics regains compliance with Nasdaq listing - TipRanks
Bone Biologics Regains Compliance with Nasdaq Continued Listing Requirements - Business Wire
Bone Morphogenetic Protein Market Expected to Hit USD 12.3 Billion by 2032 with a Remarkable 5.03% CAGR - industrytoday.co.uk
Bone Biologics Co. (NASDAQ:BBLG) Short Interest Update - Defense World
Bone Biologics (OTC:BBLG) Trading Down 11.7% – Should You Sell? - Defense World
Bone Biologics Corp (BBLG) 財務データ
収益
当期純利益
現金流量
EPS
0.71%
1.71%
大文字化:
|
ボリューム (24 時間):